InSilicoTrials – a leading provider of artificial intelligence and simulation tools for drug and medical device development, and IBSA Group – one of the major players worldwide in the fields of Reproductive Medicine and hyaluronic acid-based products, have partnered to revolutionize drug development processes using in silico medicine. At the heart of the collaboration between the two companies lies the in silico approach, which involves the use of various computational tools, such as computer simulations and mathematical models, to study...